2021
DOI: 10.1089/jir.2020.0187
|View full text |Cite
|
Sign up to set email alerts
|

Linkage of Lambda Interferons in Protection Against Severe COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 16 publications
(13 citation statements)
references
References 19 publications
1
12
0
Order By: Relevance
“…In our previous articles, we assessed some immunological features of moderate/severe and critical COVID-19 patients with interesting results. We showed that non-intensive care unit (ICU) patients had a significantly higher amount of interferon λ1 (IFN-λ1) (836.7 ± 284.6 vs. 81.57 ± 34.25) and INF-λ2 (798.8 ± 301.5 vs. 48.32 ± 28.13) compared with ICU patients [ 15 ]. The INF-λ family or type III interferon is the most recently discovered interferon and divide into 4 members, including IFN-λ1/IL-29, IFN-λ2/IL-28 A, IFN-λ3/IL-28 B, and IFN-λ4.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In our previous articles, we assessed some immunological features of moderate/severe and critical COVID-19 patients with interesting results. We showed that non-intensive care unit (ICU) patients had a significantly higher amount of interferon λ1 (IFN-λ1) (836.7 ± 284.6 vs. 81.57 ± 34.25) and INF-λ2 (798.8 ± 301.5 vs. 48.32 ± 28.13) compared with ICU patients [ 15 ]. The INF-λ family or type III interferon is the most recently discovered interferon and divide into 4 members, including IFN-λ1/IL-29, IFN-λ2/IL-28 A, IFN-λ3/IL-28 B, and IFN-λ4.…”
Section: Discussionmentioning
confidence: 99%
“…The INF-λ family or type III interferon is the most recently discovered interferon and divide into 4 members, including IFN-λ1/IL-29, IFN-λ2/IL-28 A, IFN-λ3/IL-28 B, and IFN-λ4. INF-λ receptor 1 (INF-λR1) and IL-10R2 are the heterodimeric receptors of INF-λ [ 15 ]. Since the expression of INF-λR1 is primarily limited to the respiratory tract epithelial cells, INF-λ has a major role in mucosal immunity and viral respiratory tract infection [ [15] , [16] , [17] ].…”
Section: Discussionmentioning
confidence: 99%
“…Viroporins localized in the subcellular membranes of these lung airway epithelial cells is the primary cause of ionic imbalance and thus can be potential therapeutic targets against ARDS, which is the primary reason for fatality in SARS-CoV-2 infection [72,73]. Transcriptomics analysis from patient samples affected with SARS-CoV-2 showed an upregulation in inflammatory response mediated by several interleukins and interferons [74] which are probably regulated by NFкB [75]. Increase in CD40 [76], IL-6 [77], IL-12 [78] and IL-33 [79] transcripts strongly correlate with similar expression patterns of differentially expressed genes in Acute Lung Injury, ARDS and pulmonary fibrosis.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, in mice, the administration of pegylated (PEG)-IFN-λ1a diminished SARS-CoV-2 replication [ 114 ]. Interestingly, in observational studies, increased IFN-λ1 and IFN-λ2 levels in serum were associated with a better prognosis [ 115 , 116 ]. Based on these data, clinical trials have begun to evaluate the effect of PEG-IFN-λ1a therapy in COVID19 patients, which have shown contradictory results.…”
Section: Therapeutics Targeting Innate Immune Systemmentioning
confidence: 99%